Intensify, resuscitate or palliate: decision making in the critically ill patient with haematological malignancy

Blood Reviews
Quentin A Hill

Abstract

The survival prospects of critically ill patients with haematological malignancy (HM) are reviewed, as are the variables which might influence decisions about the limitation of life sustaining therapies (LLST). Approximately 40% of patients with HM admitted to ICU survive to hospital discharge and a broad admission policy is warranted. Short term survival is predicted by the severity of the underlying physiological disturbance rather than cancer specific characteristics, although the prognostic importance of neutropenia and prior stem cell transplantation remains to be clarified. Survival to hospital discharge in cancer patients following cardio-pulmonary resuscitation (CPR) is only 6-8%. Poor performance status and progressive deterioration despite ICU support appear to predict worse outcome. Patients should be provided with realistic information in order to make an informed decision about CPR. Decisions about LLST must be individualised. Consideration should be given to the patient's wishes and prognosis, the immediate clinical circumstances and their potential reversibility.

References

Mar 1, 1992·The American Review of Respiratory Disease·D P Schuster
Mar 1, 1992·The American Review of Respiratory Disease·S W Crawford, F B Petersen
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J C Chevrolet, P Jolliet
Jan 1, 1990·Intensive Care Medicine·F BrunetJ F Monsallier
Jan 1, 1989·Critical Care Medicine·S J DenardoP E Bellamy
Jan 1, 1988·Intensive Care Medicine·C TorrecillaE Dominguez de Villota
Jul 1, 1988·Chest·S G PetersD R Gracey
Dec 26, 1986·JAMA : the Journal of the American Medical Association·M S EwerP V Balakrishnan
Oct 1, 1985·Critical Care Medicine·W A KnausJ E Zimmerman
Jan 1, 1984·Critical Care Medicine·R EstopaC Rozman
Mar 1, 1982·Archives of Internal Medicine·M J HauserH Baier
Mar 1, 1995·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·J P Sculier, E Markiewicz
Feb 10, 1993·JAMA : the Journal of the American Medical Association·D V SchapiraA Jarrett
Jun 14, 1993·Archives of Internal Medicine·M RosenbergD ] Hickham D corrected to Hickam
Jun 13, 1996·The New England Journal of Medicine·S J DiemJ A Tulsky
Sep 11, 1996·JAMA : the Journal of the American Medical Association·J R Le GallD Teres
Jun 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F BlotB Escudier
Sep 10, 1998·American Journal of Respiratory and Critical Care Medicine·K J PriceB S Andersson
Jun 11, 1999·The European Respiratory Journal·D GrusonJ P Cardinaud
Dec 10, 1999·American Journal of Respiratory and Critical Care Medicine·J P KressJ B Hall
May 16, 2000·Critical Care Medicine·A J HuaringaR E Champlin
Jun 1, 2000·Annals of Emergency Medicine·C A MarcoA R Derse
Mar 29, 2001·Intensive Care Medicine·E AzoulayB Schlemmer
May 15, 2001·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·V T HoR J Soiffer

❮ Previous
Next ❯

Citations

Mar 14, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Patrick BrückAngelika Böhme
Aug 28, 2014·Intensive Care Medicine·Djamel MokartMichael Darmon
Aug 10, 2012·Blood Reviews·Andrew S EpsteinDiane E Meier
Aug 21, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Karen EscobarPablo Ramirez
Jul 23, 2016·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·Marion CornishRobert S Green
Jun 21, 2013·Nursing in Critical Care·Caroline McCaugheyMary Frances McMullin
Dec 14, 2011·Acta Anaesthesiologica Scandinavica·D MokartJ-L Blache
May 1, 2015·Journal of Palliative Medicine·Susannah K WallaceJoseph L Nates
Jul 23, 2016·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·Alan P KraguljacSangeeta Mehta
Feb 7, 2012·British Journal of Nursing : BJN·Teresa MeenaghanMary Kelly
Feb 13, 2018·BMJ Supportive & Palliative Care·Yvan BeaussantLucas Morin
Apr 4, 2019·Leukemia & Lymphoma·Priska FassbindThomas Pabst
Jan 6, 2018·Current Opinion in Supportive and Palliative Care·Sandra A Mitchell
Nov 9, 2011·AACN Advanced Critical Care·Kristi BeattyPolly Mazanec
Nov 14, 2018·Current Oncology Reports·Marieberta VidalEduardo Bruera
Apr 29, 2018·Bone Marrow Transplantation·Colombe SaillardUNKNOWN on behalf the Groupe de Recherche en Réanimation Respiratoire du patient d’Onco-Hématologie (GRRR-OH)

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.